Clinical Trials Directory

Trials / Completed

CompletedNCT02179749

Mifepristone Treatment of Alcohol Use Disorder

Glucocorticoid Antagonist Treatment of Alcohol Use Disorder

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
103 (actual)
Sponsor
The Scripps Research Institute · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This is an 8-week, randomized, double-blind, placebo-controlled, 2 arm, parallel groups, study of 1-week of treatment with mifepristone (0, 1200 mg/d) given in conjunction with 8 weeks of manual-guided counseling, and a follow-up visit at Week 12.

Conditions

Interventions

TypeNameDescription
DRUGMifepristone 1200 mg dailyMifepristone, 300 mg tablets, Four tablets daily/am for 1-week duration.
BEHAVIORALStandardized behavioral therapyStandardized behavioral therapy 1 time per week for 8 week duration.
DRUGPlaceboPlacebo tablets, Four tablets daily/am for 1-week duration.

Timeline

Start date
2014-09-01
Primary completion
2019-11-01
Completion
2019-11-06
First posted
2014-07-02
Last updated
2022-10-06
Results posted
2022-10-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02179749. Inclusion in this directory is not an endorsement.